This is the final episode in our three-part GENcast series, where we discuss the virtues of mechanistic modeling and how it can significantly impact critical decision-making points in the drug ...
Ligand-based drug design combines AI and QSAR modeling to prioritize drug candidates, minimizing preclinical failures and ...
On September 27, 2011, Chief Judge Randall R. Rader of the United States Court of Appeals for the Federal Circuit introduced a Model Order on E-Discovery in Patent Cases at the Eastern District of ...
The UK-led OpenBind initiative has reached a major milestone with the release of its first publicly available dataset and ...
The drug discovery and development process can be an arduous endeavor. Manufacturers spend considerable resources and money chasing down potential candidate molecules to create a potential new ...
The global pharmaceutical industry is at a critical inflection point. While the FDA Modernization Act 2.0 has cleared the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results